M.J. Bartek

622 total citations · 1 hit paper
10 papers, 489 citations indexed

About

M.J. Bartek is a scholar working on Pharmacology, Analytical Chemistry and Molecular Biology. According to data from OpenAlex, M.J. Bartek has authored 10 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Analytical Chemistry and 2 papers in Molecular Biology. Recurrent topics in M.J. Bartek's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Analytical Methods in Pharmaceuticals (3 papers) and Cancer therapeutics and mechanisms (2 papers). M.J. Bartek is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Analytical Methods in Pharmaceuticals (3 papers) and Cancer therapeutics and mechanisms (2 papers). M.J. Bartek collaborates with scholars based in United States and Germany. M.J. Bartek's co-authors include John A. Labudde, Howard I. Maïbach, Allen W. Gomoll, Daniela Gallo, John H. Weikel, Michael J. Antonaccio, Lonnie D. Adams, Richard E. Gammans, Edward H. Kerns and Robert F. Mayol and has published in prestigious journals such as Clinical Chemistry, Journal of Investigative Dermatology and European Journal of Pharmacology.

In The Last Decade

M.J. Bartek

10 papers receiving 441 citations

Hit Papers

Skin Permeability In Vivo: Comparison in Rat, Rabbit, Pig... 1972 2026 1990 2008 1972 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.J. Bartek United States 5 209 189 62 60 59 10 489
Michael P. Carver United States 9 130 0.6× 90 0.5× 61 1.0× 34 0.6× 70 1.2× 13 322
S. Makki France 12 106 0.5× 178 0.9× 45 0.7× 6 0.1× 42 0.7× 38 363
A Zesch Germany 12 223 1.1× 285 1.5× 49 0.8× 25 0.4× 52 0.9× 48 521
G. Klecak Switzerland 9 84 0.4× 355 1.9× 51 0.8× 139 2.3× 115 1.9× 10 630
Wilfred Maas Netherlands 10 210 1.0× 196 1.0× 58 0.9× 57 0.9× 52 0.9× 16 460
R Woodford United Kingdom 12 389 1.9× 360 1.9× 22 0.4× 11 0.2× 27 0.5× 22 568
J. Gazith Germany 10 30 0.1× 56 0.3× 38 0.6× 5 0.1× 228 3.9× 16 432
Margaret E. K. Kraeling United States 12 165 0.8× 133 0.7× 28 0.5× 9 0.1× 65 1.1× 22 380
Clive Roper United Kingdom 11 132 0.6× 139 0.7× 41 0.7× 134 2.2× 42 0.7× 31 423
Richard Cubberley United Kingdom 14 139 0.7× 249 1.3× 80 1.3× 121 2.0× 36 0.6× 28 503

Countries citing papers authored by M.J. Bartek

Since Specialization
Citations

This map shows the geographic impact of M.J. Bartek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Bartek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Bartek more than expected).

Fields of papers citing papers by M.J. Bartek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. Bartek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Bartek. The network helps show where M.J. Bartek may publish in the future.

Co-authorship network of co-authors of M.J. Bartek

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. Bartek. A scholar is included among the top collaborators of M.J. Bartek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. Bartek. M.J. Bartek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gomoll, Allen W., et al.. (1990). Comparability of the Electrophysiologic Responses and Plasma and Myocardial Tissue Concentrations of Sotalol and its d Stereoisomer in the Dog. Journal of Cardiovascular Pharmacology. 16(2). 204–211. 17 indexed citations
2.
Bartek, M.J., et al.. (1988). Analysis of Encainide and Metabolites in Plasma and Urine by High-Performance Liquid Chromatography. Therapeutic Drug Monitoring. 10(4). 446–452. 2 indexed citations
3.
Bartek, M.J., et al.. (1987). Liquid chromatographic determination of sotalol in plasma and urine employing solid-phase extraction and fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 421(2). 309–318. 23 indexed citations
4.
Bartek, M.J., Edward H. Kerns, Richard E. Gammans, & Daniela Gallo. (1986). Determination of bucindolol and its major metabolites in plasma by capillary gas chromatography—mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 377. 183–194. 1 indexed citations
5.
Gomoll, Allen W. & M.J. Bartek. (1986). Comparative β-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs. European Journal of Pharmacology. 132(2-3). 123–135. 42 indexed citations
6.
Bartek, M.J. & John A. Labudde. (1976). Metabolism of [14C]-quazodine in the rat, dog, and man. Toxicology and Applied Pharmacology. 36(2). 307–322. 1 indexed citations
7.
Bartek, M.J., John A. Labudde, & Howard I. Maïbach. (1972). Skin Permeability In Vivo: Comparison in Rat, Rabbit, Pig and Man. Journal of Investigative Dermatology. 58(3). 114–123. 390 indexed citations breakdown →
8.
Weikel, John H. & M.J. Bartek. (1972). Toxicologic properties and metabolic fate of haloprogin, an antifungal agent. Toxicology and Applied Pharmacology. 22(3). 375–386. 7 indexed citations
9.
Bartek, M.J., et al.. (1970). The absorption, distribution, and excretion of 3-trifluoremethyl-s-triazolo(3,4-α)isoquinoline. Toxicology and Applied Pharmacology. 17(1). 41–52. 4 indexed citations
10.
Adams, Lonnie D., et al.. (1970). Rapid Method for Homogenizing Tissue Samples for Liquid Scintillation Counting. Clinical Chemistry. 16(1). 60–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026